Puretech Health Share Discussion Threads

[colinblackbourn] 17/12/2024 07:08

Puretech gave an outlook update on 20/12/23.So I assume we will get one shortly.

[takeiteasy] 17/12/2024 06:05

dyspepsia reduction (14.1% vs. 22.2%) seems a highly significant improvement in stomach related issues from the new drug - if this has been the area where most issues had been felt with existing medicines?

[ohisay] 17/12/2024 01:19

But volume/turnover in the US today was rather disappointing,

Still there's probably a case for rethinking a full listing given other company interest is almost certain to be US based

[rambutan2] 16/12/2024 21:38

Almost unbelievable lack of response, just illustrates the dire state of the UK mkt in all sorts of ways.

[mirabeau] 16/12/2024 19:48

thanks to TOB :

[peterm35] 16/12/2024 14:59

I thought the conference call was good, I would have liked a little more meat on the bones on how they plan to move forward but that will come with time.

Sounded like Analysts were possibly expecting slightly better tolerability in general and greater efficacy in the 550mg dose. However, 850mg does showed to be as tolerable if not more tolerable in general over pirfenidone, and significantly better efficacy. The fact that 90% of patients continued with the trial in the Open Label Extension.

All told very positive, if only UK moved like US which is up 13% as I type.

[colinblackbourn] 16/12/2024 14:47

As I said there is tracker stock coming out .ftse 250 exit 23rd dec.clearly derisked now.

[rambutan2] 16/12/2024 14:43

Am rather flummoxed re lack of share price reaction to trial results - conf call didnt sound anything but very positive, which is how i read them...

[colinblackbourn] 16/12/2024 13:49

Let's wait for the 2pm webcast

[colinblackbourn] 16/12/2024 13:48

https://investors.puretechhealth.com/events/event-details/elevate-ipf-phase-2b-topline-results

[doctor 69] 16/12/2024 13:09

How much would a phase three trial cost as surely pure can go it alone

[colinblackbourn] 16/12/2024 10:02

Remember the trackers are unwinding..out of the 250 on the 23

[edwardt] 16/12/2024 09:43

yes and i suspect citi are involved - hence their bizarre movements in stock. feels to me the share price is being played with - keep low to get fees on a raise...

[colinblackbourn] 16/12/2024 09:29

The results webcast did suggest an option to raise money in the US to get the specialist biotechs on board..even though they didn't need the money

[edwardt] 16/12/2024 09:22

yeah but very little volume or share count there.

[colinblackbourn] 16/12/2024 08:59

It does have a us listing?

[edwardt] 16/12/2024 08:59

just added. own way too much but hey ho 0ff to the US we go.

[rogers49] 16/12/2024 08:47

Undervalued, another company going to US?

[takeiteasy] 16/12/2024 08:47

simply move our listing to USA ....surely now...

[babbler] 16/12/2024 08:34

Wait for USA. UK is dead.

[ohisay] 16/12/2024 08:26

They'll still be dusting off the old Liberum note which has LYT100 gross value at 378m$.
Or exactly £300m at todays Dollar rate.

Be very interesting to see what the US makes of it later today ,

[edwardt] 16/12/2024 08:23

I was expecting at least + 20p

[takeiteasy] 16/12/2024 08:16

Have any MMs actually read the RNS yet?

[babbler] 16/12/2024 08:09

Was surprised at the low open tbh. In 2022 they also did pre Xmas news and it had a really nice run.